149 related articles for article (PubMed ID: 37453866)
21. [Oral plasmablastic lymphoma in a human immunodeficiency virus positive child: a case report].
Astolfo MF; D'Antonio F; Dartiguelongue JB; Arabolaza MN; Cheistwer A; De Matteo E; Torrado L; Martínez Iriart E
Arch Argent Pediatr; 2016 Apr; 114(2):e95-9. PubMed ID: 27079412
[TBL] [Abstract][Full Text] [Related]
22. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
[TBL] [Abstract][Full Text] [Related]
23. Duodenal plasmablastic lymphoma in an human immunodeficency virus-negative patient: a case report.
Hussain AA; Shah AM; Kumar S
J Med Case Rep; 2023 Oct; 17(1):414. PubMed ID: 37777745
[TBL] [Abstract][Full Text] [Related]
24. BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S; Chandrakasan S; Leung K; Bryson E; Deeb L; Kaufman JL; Worthington-White D; Alazraki A; Schecter JM; Madduri D; Jackson CC; Zudaire E; Taraseviciute-Morris A; Babich A; Nesheiwat T; Vogel M; Lendvai N; Pacaud L; Williams KM
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37137553
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
[TBL] [Abstract][Full Text] [Related]
26. [Long-term complete remission of HIV-negative primary testicular plasmablastic lymphoma treated with bortezomib in combination with EPOCH].
Fujishima T; Kawabata Y; Michishita Y; Kitabayashi A; Takahashi N
Rinsho Ketsueki; 2022; 63(10):1386-1391. PubMed ID: 36351644
[TBL] [Abstract][Full Text] [Related]
27. An Endotracheal Plasmablastic Lymphoma.
Bots EMT; Opperman J; Bassa F; Koegelenberg CFN
Respiration; 2019; 98(6):546-550. PubMed ID: 31634891
[TBL] [Abstract][Full Text] [Related]
28. Rare presentation of orbital plasmablastic lymphoma with oral cavity involvement in an HIV-negative patient.
Podder S; Khetan P; Sivamurthy S; Mandal K
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26376702
[TBL] [Abstract][Full Text] [Related]
29. Atypical presentation of plasmablastic lymphoma in immunocompetent patient.
Khan MD; Natarajan S; Lekharaju V
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848405
[TBL] [Abstract][Full Text] [Related]
30. Plasmablastic lymphoma: from genetics to treatment.
Frontzek F; Hailfinger S; Lenz G
Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
[TBL] [Abstract][Full Text] [Related]
31. Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma.
Lipstein M; O'Connor O; Montanari F; Paoluzzi L; Bongero D; Bhagat G
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):E43-6. PubMed ID: 21856550
[TBL] [Abstract][Full Text] [Related]
32. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
[TBL] [Abstract][Full Text] [Related]
33. Dramatic treatment response of cutaneous plasmablastic lymphoma in an HIV patient: a case report.
Sakib SM; Sadler M
Clin Imaging; 2016; 40(6):1067-1069. PubMed ID: 27408991
[TBL] [Abstract][Full Text] [Related]
34. Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Pretscher D; Kalisch A; Wilhelm M; Birkmann J
Ann Hematol; 2017 Jun; 96(6):967-970. PubMed ID: 28011983
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte Génin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
[TBL] [Abstract][Full Text] [Related]
36. [Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Tissir R; Rais H; Tazi I
Pan Afr Med J; 2020; 37():22. PubMed ID: 33062124
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic analysis of HIV-negative plasmablastic lymphoma].
Chen Y; Liu Y; Luo D; Zhang F; Xu F; Ge Y; Luo X; Chen J
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):548-52. PubMed ID: 26705177
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?
Beltran BE; Quiñones P; Sanchez G; Paredes A; Moises C; Cotrina E; Torres-Cabala CA; Miranda RN; Castillo JJ
Leuk Lymphoma; 2018 Jul; 59(7):1753-1755. PubMed ID: 29081245
[No Abstract] [Full Text] [Related]
39. Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer.
Bricman L; Yengue P; Miscu C; Junius S; Waignein F; Vandenbulcke JM
Acta Gastroenterol Belg; 2021; 84(4):663-665. PubMed ID: 34965049
[TBL] [Abstract][Full Text] [Related]
40. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
Wong YP; Masir N; Chew MX
Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
